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Rapport de synthèse 
Strength of family history predicting levels of blood pressure, plasma glucose and 
cholesterol 
Valeur de l'anamnèse familiale pour la prédiction du niveau de tension artérielle, de la 
glycémie à jeun et du cholestérol. 
L'histoire familiale reflète non seulement la susceptibilité génétique d'un individu à certaines 
maladies mais également ses comportements et habitudes, notamment partagées au sein d'une 
famille. L'hypertension atiérielle, le diabète et l'hypercholestérolémie sont des facteurs de 
risque cardio-vasculaire modifiables hautement prévalent. L'association entre l'histoire 
familiale d'hypertension artérielle ou de diabète et le risque accru de développer de 
l'hypertension artérielle ou du diabète, respectivement, a été préalablement établie. Par contre, 
le lien entre l'histoire familiale de facteurs de risque cardio-vasculaire et les traits continus 
correspondants n'avaient jamais été mis clairement en évidence. De même, la signification 
d'une histoire familiale inconnue n'avait jusqu'alors pas été décrite. 
Ce travail, effectué dans le cadre de l'étude Colaus (Cohorte Lausannoise), une cohorte 
regroupant un échantillon composé de 6102 participants âgés de 35 à 75 ans sélectionnés au 
hasard dans la population lausannoise, a permis de décrire en détail la relation entre l'histoire 
familiale des facteurs de risque cardio-vasculaires et les trait correspondants dans la 
population étudiée. 
Les différentes analyses statistiques ont permis de mettre en évidence une relation forte entre 
l'histoire familiale d'hypertension artérielle, de diabète ainsi que de l'hypercholestérolémie et 
leurs traits dichotomique et continu correspondants. Les anamnèses des frères et sœurs avaient 
des valeurs prédictives positives plus élevées que les anamnèses parentales. Ceci signifie que 
les programmes de dépistage ne prenant en compte que l'histoire familiale des frères et sœurs 
seraient probablement plus efficaces que ceux qui comp01ient l'évaluation des anamnèses 
paternelle et maternelle. 
Plus de 40% des participants ignoraient l'histoire familiale d'hypertension d'au moins un des 
membres de leur famille. Ceux-ci avaient des valeurs de tension artérielle systolique plus 
élevées que ceux dont l'histoire familiale était négative, permettant de souligner la valeur 
prédictive du fait de ne pas connaître l'histoire familiale d'hypertension artérielle. Ces 
résultats montrent également que, lors d'analyses de la relation entre l'anamnèse familiale de 
facteurs de risque cardiovasculaires et leurs traits correspondants, les participants donnant des 
réponses négatives doivent être distingués de ceux qui ne connaissent pas leur anamnèse 
familiale. 
Les résultats de cette étude confirment la place centrale qu'occupe l'anamnèse familiale dans 
l'évaluation du risque cardio-vasculaire auprès de la population générale. L'importance de cet 
outil prédictif simple et bon marché ne va cesser d'augmenter avec la disponibilité croissante 
d'information génétique détaillée pour les maladies cardiovasculaires communes. 
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Abstract 
Objective: Limited information is available on the quantita-
tive relationship between family history and the correspond-
ing underlying traits. We analyzed these associations for 
blood pressure, fasting blood glucose, and cholesterol lev-
els. Methods: Data were obtained from 6,102 Caucasian par-
ticipants (2,903 men and 3,199 women) aged 35-75 years 
using a population-based cross-sectional survey in Switzer-
land. Cardiovascular disease risk factors were measured, and 
the corresponding family history was self-reported using a 
structured questionnaire. Results: The prevalenc'e of a posi-
tive family history (in first-degree relatives) was 39.6% for hy-
pertension, 22.3% for diabetes, and 29.0% for hypercholes-
terolemia. Family history was not known for at least one 
family member in 41.8% of participants for hypertension, 
14.4% for diabetes, and 50.2% for hypercholesterolemia. A 
positive family history was strongly associated with higher 
levels of the corresponding trait, but not with the other 
traits. Participants who reported not to know their family 
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history of hypertension had a higher systolic blood pressure 
than participants with a negative history. Sibling histories 
had higher positive predictive values than parental histories. 
The ability to discriminate, calibrate, and reclassify was best 
for the family history of hypertension. Conclusions: Family 
history of hypertension, diabetes, and hypercholesterol- ,r 
emia was strongly associated with the corresponding di-1 
chotomized and continuous phenotypes. 
Copyright© 2009 S. Karger AG, Basel 
Family history not only captures genetic susceptibility 
to a specific disease but also behaviors and life styles that 
are shared across members of the same family. Hyper-
tension, diabetes mellitus, and hypercholesterolemia are 
highly prevalent modifiable cardiovascular risk factors 
that are known to aggregate in families [1-3]. A positive 
family history of hypertension or diabetes is an indepen-
dent risk factor for hypertension [4] or diabetes [3, 5-8], 
respectively. Whether a positive family history of hyper-
cholesterolemia is able to capture any familial aggrega-
tion and hencc represents an independent risk factor for 
the disease is more controversial, as it has been reported . 
in_some studies [3, 9, 10] but not in others [11, 12]. 
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Although numerous studies have analyzed the risk of 
cardiovascular disease associated with a positive family 
history of risk factors, considerably less data are available 
on the relationship between a positive family history and 
the corresponding level of the continuous trait [10, 13]. 
This is especially true for hypercholesterolemia in adults, 
with little population-based data available on family his-
tory [10, 14]. In addition, data on the cardiovascular risk 
of subjects who report not to know their family history of 
hypertension, diabetes, and/or hypercholesterolemia are 
scarce [13, 15, 16]. 
We took advantage of the CoLaus study to explore in 
more detail the relationship between family history and 
related traits. The CoLaus study is a population-based 
study aiming at unraveling the genetic determinants of 
cardiovascular risk factors [17]. We analyzed (1) the rela-
tionship between the family history of hypertension, dia-
betes, or hypercholesterolemia and the corresponding 
continuous phenotype in a large population-based study, 
(2) whether knowledge of a specific family history was 
associated with the corresponding phenotype and hence 
with cardiovascular risk, and (3) whether personal aware-
ness of hypertension, diabetes, or hypercholesterolemia 
changed these associations. 
Subjects and Methods 
Study Population 
Recruitment began in June 2003 and ended in May 2006. The 
complete list of Lausanne inhabitants aged 35-75 years (n = 
56,694) was provided by the population registry of the city. A sim-
ple non-stratified random sample of35% of the overall population 
was drawn. Inclusion criteria were: (a) written informed consent, 
(b) aged 35-75 years, (c) available examination and blood sample, 
and (d) Caucasian descent. Of the 6,188 participants, we excluded 
86 subjects because theywere adopted (n = 62), or because of miss-
ing blood pressure (n = 6), la bora tory (n = 11), questionnaire (n = 
5), and anthropometric (n = 2) data, leaving 6,102 for the main 
analyses. The studywas approved bythe Ethics Committee of the 
Faculty of Biology and Medicine of Lausanne. In Switzerland 
health insurance is mandatory, and access to health care is uni-
versal. Therefore, every inhabitant has easy access to cardiovas-
cular screening. In Lausanne the screening guidelines are based 
on the US Preventive Services Task Force guidelines [18]. 
Questionnaire Data 
Trained health professionals used a standardized question-
naire on socio-demographic characteristics and family history. 
Subjects were asked questions about hypertension, diabetes, and 
hypercholesterolemia in their father, mother, and siblings. The 
following questions were asked: 'Is your father still alive?', 'Does 
(did) your father have hypertension?', 'Ifyes, at what age was hy-
pertension diagnosed?', 'Does (did) your father have diabetes?', 
'Does (did) your father have elevated cholesterol levels?'. Possible 
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answers were 'yes', 'no', and' don't know'. The same questions were 
asked for the mother's history. 'Do you have siblings?', 'If yes, how 
many siblings do you have?', 'How man y of your siblings suffer 
from hypertension? Diabetes? Hypercholesterolemia?'. A 'don't 
know' answer could be provided. For awareness, the following 
questions were asked: 'Did a medical doctor ever tell you that you 
have elevated blood pressure (hypertension)?', 'Were you ever told 
that you have diabetes? Hypercholesterolemia?'. Definitions of 
hypertension, diabetes, or hypercholesterolemia were not provid-
ed to participants. None of the subjects who reported not to have 
diabetes or hypertension reported to be treated for hypertension 
or diabetes. We included the 44 participants who reported not to 
have hypercholesterolemia but were treated with statins in the 
group of persans unaware of being affected. 
Assessment Process and Data Collection 
Participants attended the outpatient clinic of the University 
Hospital of Lausanne (CHUV) in the morning after an overnight 
fast. For the purpose of the present analysis, smoking was defined 
as present if a participant reported to be a current smoker at the 
time of examination; alcohol consumption was defined as present 
for participants reporting to drink alcohol at least once a day. 
Body mass index (BMI) was defined as weight divided by height 
in meter squared. Blood pressure and heart rate were measured 3 
times on the left arm after at least 10 minutes rest in the seated 
position using a clinically validated automatic oscillometric de-
vice (Omron HEM-907, Matsusaka, Japan) [19] with an appropri-
ately sized cuff. The average of the 2nd and 3rd readings was used 
for analyses. Hypertension was defined as a mean systolic blood 
pressure 2: 140 mm Hg and/or a diastolic blood pressure 2: 90 mm 
Hg and/or presence of anti-hypertensive drug treatment. Ave-
nons blood sample was collected from each participant under 
fasting conditions. Blood tubes were centrifuged at 1,500 rprn for 
10 min at 4 °C within 2 h of admission. The CHUV Clinical Lab-
oratory, which is ISO 9001 certified and regularly checked by the 
Swiss Centre for Quality Contrai, conducted ail measurements in 
a Modular P apparatus (Roche Diagnostics, Switzerland). Glucose 
and blood lipids were measured using standard laboratory meth-
ods. Diabetes was defined as a fasting blood glucose 2: 126 mg/dl 
or presence of any antidiabetic drug (including insulin). Two def-
initions were used for hypercholesterolemia. The first was de-
fined as a fasting blood cholesterol 2:242 mg/dl or under lipid 
lowering treatrnent. The second definition took into account fast-
ing LDL-cholesterol values 2: 161 mg/dl or 2: 101 mg/dl in par-
ticipants at high risk of cardiovascular diseases (i.e., a history of 
myocardial infarction, stroke, coronary artery disease, or diabe-
tes) or under lipid lowering treatrnent. 
Statistical Analyses 
Statistical analyses were perforrned using Stata 9.2 (Stata Corp., 
College Station, USA). Quantitative data were expressed as mean 
± standard deviation or as median and interquartile range. We 
conducted multiple linear regressions using (1) systolic blood pres-
sure, (2) fasting blood glucose, and (3) fasting serurn cholesterol 
levels as the dependent variables. For ail traits, the values of the 
dependent variables and the residuals of the regression models 
were approximately normally distributed. For age- and sex-adjust-
ed models we used F tests to compare adjusted rneans between 
groups. For full models, age, sex, education level, smoking status, 
alcohol consumption, weight, height, and treatment (coded as 0/1 
Wandeler /Paccaud/Vollenweider / 
Waeber/Mooser /Bochud 
for the absence/presence of current antihypertensive drugs for hy-
pertension, lipid lowering drugs for hypercholesterolemia, and an-
tidiabetic drugs for diabetes) were added as covariates in the mod-
els. We conducted regression diagnostics to assess non-linearity 
and heteroscedasticity. We tested for collinearity using the 'collin' 
fonction in Stata. We did not systematically test ail two-way inter-
actions but conducted separate analyses by sex. In addition, we as-
sessed whether any of the family history was associated with sys-
tolic and diastolic blood pressure, fasting glucose, and total choles-
terol using multiple linear regressions (e.g., whether a positive 
family history of hypertension was associated with higher fasting 
blood glucose, etc.). To assess the influence of outlier observations, 
we conducted sensitivity analyzes using continuons traits win-
sorized at percentiles 1 and 99 (i.e., replacing values lying away 
from percentiles 1 or 99 by percentiles 1 or 99, respectively). Fam-
ily history of cardiovascular risk factors in siblings was considered 
as 'don't know' when the history of at least one sibling was un-
known. We also conducted separate analyses for men and women, 
for treated and untreated subjects, and used a definition for a fam-
ily history of hypertension that took into account the age of diag-
nosis of hypertension in the parent. After excluding 'don't know' 
responses, we conducted multiple logistic regressions adjusted for 
age, sex, educational level, BMI, smoking, and alcohol consump-
tion to measure the association between a positive family history 
and the risk of the corresponding dichotomized risk factor. We also 
conducted these latter analyses using the combined negative and 
'don't know' responses as a reference group. We also estimated the 
ability of family history (1) to discriminate the dichotomized risk 
factor using area under the curve (AUC), (2) to calibrate the risk 
factor using the Hosmer-Lemeshow test, and (3) to reclassify the 
dichotomized risk factor using the net reclassification index [20]. 
Separate linear and logis tic regression analyses including only par-
ticipants who were unaware of their own disease status (i.e., hyper-
tension, diabetes, and/or hypercholesterolemia) were also con-
ducted. After excluding 'don't know' responses, we also calculated 
the sensitivity, specificity, and positive and negative predictive val-
ues of the family history to predict the corresponding disease in 
participants, including exact binomial confidence intervals. 
Results 
Participants' Characteristics 
Participants' characteristics are listed in table 1. Differ-
ences between men and women were statistically signifi-
cant for all variables except for total cholesterol levels (p = 
0.09) and personal history of stroke (p = 0.10). Women had 
lower education levels and were less frequently treated for 
hypertension, diabetes, and/or dyslipidemia than men. 
Men had higher levels of systolic and diastolic blood pres-
sure, fasting blood glucose and triglyceride, and a lower 
HDL-cholesterol level than women, whereas total choles-
terol levels were similar in men and women. The preva-
lence of hypertension, diabetes, and hypercholesterol-
emia (lst and 2nd definitions, see Subjects and Methods) 
was 35.7%, 6.2%, 33.8%, and 22.9%, respectively. 
Cardiovascular Family History 
Prevalence of Positive and Unreported ('Don 't Know') 
Family History 
36% of the fathers and 56% of the mothers of the par-
ticipants were reported to be alive at the time of the in-
terview. The prevalence of a positive family history (fa-
ther, mother, and/or siblings) was 39.6% for hypertension, 
22.3% for diabetes, and 29.0% for hypercholesterolemia. 
The prevalence of a positive paternal, maternal, and sib-
ling history was 16.5%, 23.9%, and 12.9% for hyperten-
sion, 9.0%, 10.5%, and 6.5% for diabetes, and 13.9%, 
12.7%, and 10.0% for hypercholesterolemia, respectively 
(table 2). The prevalence of' don't know' responses for at 
least one family member was 41.8% for hypertension, 
14.4% for diabetes, and 50.2% for hypercholesterolemia. 
The paternal, maternal, and sibling history was reported 
not to be known by 30.3%, 19.1%, and 16.5% of the par-
ticipants for hypertension, 8.7%, 4.5%, and 5.7% for dia-
betes, and 38.2%, 29.6%, and 22.0% for hypercholesterol-
emia, respectively (table 2). 
Association of a Positive Family History with 
Corresponding Cardiovascular Risk Factors 
Age- and sex-adjusted systolic blood pressure was 
higher in participants with a positive family history of 
hypertension than in participants with a negative or un-
reported history. Similar observations were made for 
fasting blood glucose and family history of diabetes, as 
well as for fasting total cholesterol levels and family his-
tory of hypercholesterolemia (table 2). Results were simi-
lar for diastolic blood pressure (data not shown). In mul-
tiple linear regressions adjusting for age, sex, treatment, 
BMI, educational level, smoking, and alcohol consump-
tion a positive family history was also independently as-
sociated with the corresponding trait (i.e., blood pres-
sure, fasting blood glucose, and cholesterol) (data not 
shown). The systematic associations of a positive family 
history with increased cardiovascular risk factor were 
specific to the corresponding trait (i.e., family history of 
hypertension was associated with increased blood pres-
sure but not with increased fasting blood glucose or cho-
lesterol). 
Association of Unreported Family History with 
Corresponding Cardiovascular Risk Factors 
Participants unable to report on their family history 
(father, mother, or siblings) of hypertension had a higher 
systolic blood pressure than those with a negative history 
(table 2). The same association was observed for fasting 
glucose levels and a missing history of diabetes, although 
it did not reach statistical significance in siblings. Par-
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Table 1. Participants' characteristics overall and by sex 
Total Men Women 
(n = 6,102) (n = 2,903) (n = 3,199) 
Age (years) 53.0± 10.9 52.6± 10.9 53.5±10.7 
Education level (%) 
Less than high school 20.7 17.4 23.8 
Apprenticeship 36.9 37.9 36.0 
High school /GED 23.8 22.7 24.8 
More than high school 18.5 22.0 15.4 
Antihypertensive treatment (%) 18.1 19.9 16.5 
Antidiabetic treatment (%) 3.7 5.5 2.0 
Lipid lowering treatment (%) 11.5 14.2 9.0 
Current smoker (%) 26.7 29.1 24.9 
Daily alcohol drinker (%) 25.4 36.0 15.7 
Weight (kg) 73.6± 15.0 81.5 ± 13.2 66.4±12.8 
Height (cm) 168.6 ± 9.3 175.0± 7.3 162.8±6.7 
Body mass index (kg/m2) 25.8 ±4.5 26.6±4.0 25.l ±4.8 
Hypertension(%) 35.7 42.0 30.1 
Diabetes (%) 6.2 9.3 8.1 
Hypercholesterolemia 1 (%)a 33.8 35.l 32.6 
Hypercholesterolemia 2 (%)b 22.9 26.9 19.4 
SBP (mm Hg) 128.2 ± 17.9 132.1±16.6 124.7± 18.3 
DBP (mm Hg) 79.3±10.8 81.3 ± 10.7 77.5±10.6 
Glucose (mg/dl) 99.9 ± 20.5 104.0± 21.8 96.1±18.4 
Total cholesterol (mg/dl) 218.0 ±40.2 216.8 ± 40.6 218.8 ± 39.8 
HDL-cholesterol (mg/dl) 63.6±17.2 56.2± 14.0 70.6±16.8 
Triglycerides (mg/dl) 123.7± 105.0 147.7± 136.2 103.2±57.9 
Persona! history 
Acute myocardial infarction (n) 97 75 22 
Stroke (n) 70 39 31 
Data are means ± SD, unless stated otherwise. Differences between men and women were statistically sig-
nificant for al! variables except for total cholesterol levels (p = 0.09) and persona! history of stroke (p = 0.10). 
SBP = Systolic blood pressure; DBP = diastolic blood pressure 
a Hypercholesterolemia was defined as a fasting blood cholesterol 2242 mg/dl or under lipid lowering treat-
ment. 
b Hypercholesterolemia was defined as a fasting LDL-cholesterol 2161 mg/dl or 2101 mg/dl in participants 
at high risk of cardiovascular diseases (i.e., a history of myocardial infarction, stroke, coronary artery disease, 
or diabetes) or under lipid lowering treatment. 
ticipants with an unreported family history ofhypercho-
lesterolemia had cholesterol levels similar to those of par-
ticipants with a negative family history. 
Association of the Number of Positive Family Histories 
with Cardiovascular Risk Factors 
After adjusting for age, sex, educational level, BMI, 
smoking, alcohol consumption, and treatment, mean 
systolic blood pressure, fasting glucose, and cholesterol 
levels linearly increased with an increasing number of 
first-degree relatives with a positive history of hyper-
tension, diabetes, or hypercholesterolemia, respectively 
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(fig. 1). The three risk factors were significantly higher 
with every added positive family history (p < 0.001). Par-
ticipants who did not know their family history (n = 
2,917) were excluded from these analyses in order to com-
pare positive with negative responses only. 
Association of the Number of Unreported Family 
Histories with Continuous Cardiovascular Risk 
Factors 
The same approach was used to determine differences 
i_n mean systolic blood pressure, glucose, and cholesterol 
level when considering the number of 'don't know' re-
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Table 2. Age- and sex-adjusted systolic blood pressure, fasting glucose, and total cholesterol levels by family history status 
Father Mother 
no don't know yes no 
History of hypertension 
Il(%) 3,250 (53.3) 1,848 (30.3) 1,004 (16.5) 3,479 (57.0) 
Age (years) 52.0±0.2 56.l ±o.2n 50.7±0.3b,c 52.0±0.2 
SBP (mm Hg) 127.1±0.3 128.8 ±0.4" 131.0 ± o.5b,' 127.0 ± 0.3 
Glucose (mmol/l) 5.52±0.02 5.60 ± 0.03" 5.50 ± 0.03 5.52±0.02 
Cholesterol (mmol/l) 5.59 ± 0.02 5.60 ± 0.02 5.54±0.03 5.57±0.02 
History of diabetes 
n(%) 5,025 (82.4) 530 (8.7) 547 (9.0) 5,189 (85.0) 
Age (years) 52.9±0.2 56.9 ±0.5'1 50.5 ± o.5h,' 52.7±0.l 
SBP (mm Hg) 128.1±0.2 129.3 ±0.7 128.7±0.7 128.0 ± 0.2 
Glucose (mmol/l) 5.51±0.02 5.68 ± 0.05" 5.76 ± o.o5h 5.50±0.02 
Cholesterol (mmol/l) 5.59 ± 0.01 5.59 ± 0.04 5.55 ± 0.04 5.59 ± 0.01 
Hist01y of hypercho/esterolemia 
n(%) 2,924 (47.9) 2,329 (38.2) 849 (13.9) 3,524 (57.8) 
Age (years) 52.3 ±0.2 55.9 ± 0.2" 47.6 ± 0.4b, c 52.2±0.2 
SBP(mmHg) 127.6 ± 0.3 128.8 ±0.3" 129.1 ± o.5b 127.7±0.3 
Glucose (mmol/l) 5.54± 0.02 5.56±0.02 5.55±0.04 5.52 ± 0.02 
Cholesterol (mmol/l) 5.56± 0.02 5.57±0.02 5.72±0.04b,c 5.56±0.02 
Data are means ± SE. SBP = Systolic blood pressure. 
"p < 0.05 for the difference between 'don't know' and 'no' responses. 
b p < 0.05 for the difference between 'yes' and 'no' responses. 
'p < 0.05 for the difference between 'yes' and 'don't know' responses. 
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Fig. 1. Quantitative relationships between the number of relatives 
with a positive history of hypertension (a), diabetes (b), and hy-
percholesterolemia (c) and the corresponding underlying trait. 
Traits are adjusted for age, sex, BMI, alcohol consumption, smok-
ing, treatment, and education level. 'Don't know' responses were -
excluded. 
Siblings 
don'tknow yes no don't know yes 
1,167 (19.1) 1,456 (23.9) 3,825 (70.5) 897 (16.5) 702 (12.9) 
57.2± 0.2" 52.3± 0.3' 51.1±0.2 56.5 ± 0.3" 57.4 ± 0.4b 
129.1±0.5'1 130.6 ± 0.4b, c 127.1±0.3 129.l ± 0.5" 132.4 ± 0.6b, c 
5.61±0.03" 5.56±0.03 5.53 ± 0.02 5.57±0.04 5.59±0.04 
5.60± 0.03 5.60±0.3 5.58±0.02 5.60±0.03 5.50 ± 0.04' 
275 (4.5) 638 (10.5) 4,763 (87.8) 308 (5.7) 353 (6.5) 
58.2± 0.6" 53. 7 ± 0.4b ,c 52.1±0.2 57.6±0.6" 58.3±0.é 
130.0 ± 0.9" 129.2 ± 0.6 127.8 ± 0.2 130.0 ± 0.9" 130.o ±o.8h 
5.65 ± 0.07" 5.86 ± 0.04b, c 5.50± 0.02 5.61 ±0.06 6.06 ± 0.06b, c 
5.47± 0.06 5.63 ±0.04' 5.57 ± 0.01 5.49 ± 0.06 5.63 ±0.05 
1,804 (29.6) 774 (12.7) 3,684 (67.9) 1,195 (22.0) 545 (10.0) 
56.1 ±0.2" 49.4±0.4b,c 51.3±0.2 56.5± 0.3" 55.o ± o.4h,' 
129.3 ± 0.4" 128.4±0.6 127.7 ± 0.3 129.5 ± 0.5'1 128.1 ±0.7 
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Table 3. Risle of hypertension, diabetes, or hypercholesterolemia associated with a positive family history 
U nadjusted Age- and sex-adjusted Pully adjusted 1 Pully adjusted 2 
OR 95% CI OR 95% CI OR 95%CI OR 95% CI 
Hypertension (n) (3,196) (3,196) (3,185) (5,424) 
Father history 1.41 1.19-1.68 1.91 1.58-2.33 2.16 1.75-2.66 1.61 1.30-2.02 
Mother histo1y 1.63 1.39-1.93 2.12 1.76-2.55 2.10 1.72-2.55 1.45 1.19-1.76 
Sibling history 3.38 2.76-4.14 2.85 2.28-3.56 2.73 2.15-3.47 1.54 1.20-1.97 
Number of relatives 
0 1.00 1.00 1.00 1.00 
1 1.37 1.15-1.62 1.79 1.48-2.18 1.94 1.58-2.39 1.40 1.16-1.68 
2 2.25 1.77-2.85 2.98 2.28-3.90 3.08 2.31-4.10 1.51 1.10-2.07 
3 5.79 3.99-8.40 6.92 4.58-10.46 6.79 4.40-10.49 2.95 1.83-4.79 
Diabetes (n) (4,722) (4,722) (4,718) (5,424) 
Father history 2.14 1.51-3.02 2.77 1.93-3.98 2.80 1.91-4.10 2.03 1.40-2.94 
Mother histo1y 2.68 1.95-3.67 2.85 2.05-3.97 2.70 1.90-3.83 2.63 1.93-3.58 
Sibling history 4.59 3.28-6.41 4.00 2.81-5.70 3.34 2.29-4.85 2.83 2.01-3.97 
Number of relatives 
0 1.00 1.00 1.00 1.00 
2.74 2.05-3.65 3.01 2.23-4.07 2.95 2.16-4.05 2.45 1.86-3.23 
2 5.30 3.22-8.74 5.36 3.15-9.12 3.92 2.23-6.90 3.09 1.84-5.18 
3 17.26 7.41-40.24 20.25 8.37-48.98 18.22 7.26-45.73 17.06 7.69-37.86 
Hypercholesterolemia (n) (2,727) (2,727) (2,720) (5,424) 
Father history 1.20 0.99-1.46 1.80 1.45-2.22 1.93 1.55-2.40 1.51 1.24-1.84 
Mother history 1.08 0.86-1.34 1.40 1.11-1.77 1.39 1.10-1.77 1.16 0.94-1.43 
Sibling histo1y 2.12 1.66-2.72 2.11 1.62-2.74 1.96 1.50-2.56 1.42 1.14-1.78 
Number of relatives 
0 1.00 1.00 1.00 1.00 
1.13 0.94-1.36 1.59 1.30-1.96 1.66 1.35-2.05 1.27 1.18-1.51 
2 1.39 1.01-1.91 1.98 1.41-2.76 1.92 1.36-2.70 1.54 1.13-2.09 
3 3.73 2.78-6.12 5.06 3.02-8.50 4.97 2.92-8.45 2.77 1.66-4.64 
OR= Odds ratio; 95% CI= 95% confidence interval. 
Data are results from multiple logistic regression models using either negative histories (fully adjusted 1) or negative and 'don't 
know' histories (fully adjusted 2, n = 5,424) as the reference group. Pully adjusted models included the use of age, sex, education level, 
body mass index, smoking, and alcohol consumption as covariates. 
sponses, using the same multivariable adjustment (fig. 2). 
Positive responses were excluded in order to compare 
negative with 'don't know' responses only, reducing the 
sample size to 3,803 participants. Systolic blood pressure 
was higher with every additional 'don't know' response, 
with statistically significant (p < 0.05) differences be-
tween 0 and 2, and 0 and 3 unreported histories. No such 
association was found with the other risk factors. 
Association of a Positive Family History with the Risk 
of the Dichotomized Cardiovascular Risk Factors 
A positive history of hypertension in the father, the 
mother, or siblings increased the risk of hypertension by 
approximately 50% in fully adjusted models (table 3). 
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With a corresponding family history, the risk of diabetes 
increased by about 150%. By contrast, a maternal history 
of hypercholesterolemia was not associated with in-
creased risk of hypercholesterolemia in the subject. Using 
an alterna te definition of hypercholesterolemia by taking 
only LDL-cholesterol values into account did not change 
those results significantly but tended to weaken the as-
sociations between family history and hypercholesterol-
emia. There was a trend toward increased risk of hyper-
tension, diabetes, and hypercholesterolemia with an in-
creasing number of first-degree relatives with a positive 
history. This trend was the strongest for diabetes. For 
_ each trait, the odds ratios were not attenuated and some-
tilnes strengthened with the fully adjusted model. Asso-
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Table 4. Sensitivity, specificity, and predictive values of family history for the risk of the corresponding disease 
n 'Don't know' Sensitivity, % Specificity, % PPV,% NPV,% 
responses (95% CI) (95% CI) (95% CI) (95% CI) 
Hypertension 
Father history 4,244 excluded 33.4 (30.5-36.3) 79.5 (78.1-80.9) 34.8 (31.8-37.8) 78.5 (77.0-79.9) 
6,084 included 21.8 (19.8-23.9) 85.4 (84.3-86.4) 34.8 (31.8-37.8) 75.3 (74.1-76.5) 
Mother history 4,921 excluded 40.8 (38.1-43.6) 74.3 (72.9-75.8) 35.1 (32.7-37.6) 78.7 (77.3-80.0) 
6,084 included 31.8 (29.5-34.2) 79.0 (77.8-80.2) 35.1 (32.7-37.6) 76.4 (75.2-77.6) 
Sibling history 4,514 excluded 31.3 (28.6-34.2) 89.7 (88.7-90.7) 50.4 ( 46.6-54.1) 79.7 (78.4-81.0) 
5,409 included 24.9 (22.7-27.2) 91.3 (90.4-92.1) 50.4 ( 46.6-54.1) 77.4 (76.2-78.6) 
Diabetes 
Father histo1y 5,458 excluded 16.8 (12.3-22.1) 90.4 (89.6-91.2) 7.6 (5.5-10.2) 95.9 (95.3-96.4) 
5,967 included 13.5 (9.9-17.8) 91.2 (90.4-91.9) 7.6 (5.5-10.2) 95.2 (94.5-95.7) 
Mother hist01y 5,711 excluded 24.5 (19.5-30.0) 89.7 (88.8-90.5) 10.7 (8.4-13.3) 95.9 (95.3-96.5) 
5,967 included 22.0 (17.5-27.1) 90.1 (89.3-90.8) 10.7 (8.4-13.3) 95.6 (95.0-96.1) 
Sibling history 5,011 excluded 25.6 (20.2-31. 7) 94.0 (93.2-94.6) 17.2 (13.4-21.6) 96.3 (95.7-96.8) 
5,310 included 22.4 (17.5-27.9) 94.3 (93.6-94.9) 17.2 (13.4-21.6) 95.8 (95.2-96.3) 
Hypercho/esterolemia 
Father history 3,631 excluded 29.4 (26.3-32.8) 79.7 (78.2-81.2) 28.6 (25.5-31.8) 80.4 (78.9-81.8) 
5,798 included 15.9 (14.1-17.9) 86.7 (85.7-87.7) 28.6 (25.5-31.8) 75.5 (74.5-76.7) 
Mother history 4,130 excluded 26.5 (23.7-29.5) 84.6 (83.3-85.8) 33.7 (30.3-37.3) 79.6 (78.2-80.9) 
5,798 included 17.2 (15.3-19.3) 88.7 (87.7-89.6) 33.7 (30.3-37.3) 76.2 (75.0-77.4) 
Sibling history 4,019 excluded 23.8 (21.1-26.7) 90.1 (89.0-91.l) 41.4 (37.2-45.8) 80.0 (78.7-81.3) 
5,154 included 17.1 (15.1-19.3) 92.1 (91.2-92.9) 41.4 (37.2-45.8) 77.1 (75.9-78.3) 
'Don't know' responses were either excluded or coded as negative responses (included) in the analyses. 
95% CI= 95% confidence intervals calculated using an exact binomial distribution; PPV =positive predictive value; NPV = nega-
tive predictive value. 
ciations obtained using the combination of negative and 
'don't know' histories as the reference group were sub-
stantially weaker than those excluding 'don't know' re-
sponses (last column of table 3). 
Ability of Family History ta Predict the Risk of the 
Corresponding Disease 
For hypertension, diabetes, and hypercholesterolemia, 
a negative sibling history was more specific to exclude the 
presence of the underlying disease in the participant than 
either paternal or maternal history (table 4). Analogously, 
a positive sibling history was better in predicting disease 
in the participant than either paternal or m'aternal histo-
ries. The positive predictive value was highest for the 
family history of hypertension, in particular for sibling 
history, and lowest for the family history of diabetes. 
Combining 'don't know' with negative responses resulted 
in lower sensitivities and higher specificities of family 
history to predict the corresponding disease whereas it 
did not alter positive predictive values and only slightly 
modified negative predictive values. 
Cardiovascular Family History 
Ability of Family History ta Discriminate, Calibrate, 
and Reclassify the Dichotomized Cardiovascular Risk 
Factors 
The inclusion of family history of hypertension, dia-
betes, or hypercholesterolemia in a model including only 
age and sex as covariates always significantly improved 
the AUCs to predict the corresponding dichotomized 
risk factor for hypertension and diabetes, except for the 
mother's history of hypercholesterolemia (table 5). Tak-
ing 'don't know' responses into account always led to 
similar or better AU Cs than considering 'don't know' as 
negative responses. The calibration of the models includ-
ing family history were not always good as reflected by 
low Hosmer-Lemeshow p values (table 5), in particular 
for the family history of hypercholesterolemia. Adding 
family history to age and sex led to improved reclassifica-
tion of hypertension status, whether or not 'don't know' 
responses vrere included in the models (table 5). This was 
only observed for sibling and overall family history for 
_ hypercholesterolemia. Family history of diabetes had lit-
tle to no ability to reclassify diabetes status. 
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Fig. 2. Quantitative relationships between the number of relatives 
with unknown history of hypertension (a), diabetes (b), and hy-
percholesterolemia (c) and the corresponding underlying trait. 
Traits are adjusted for age, sex, BMI, alcohol consumption, smok-
ing, treatment, and education level. Positive responses were ex-
cluded. *Statistically significant (p < 0.05) differences between 0 
and 2 and between 0 and 3 unreported histories. 
Sensitivity Analyses 
Analyses conducted using winsorized continuons 
phenotypes led to similar results, i.e., differing by 50% or 
less of a standard error for systolic blood pressure and 
cholesterol and by 17-183% of a standard error for fasting 
glucose without changing our conclusions. Results were 
similar when analyses were stratified by sex or treatment 
status or when a family history of hypertension was con-
sidered as positive only if hypertension was reported to 
have been diagnosed before the age of 60 years. We con-
ducted the sa me analyses in the subgroups of participants 
who were unaware of having a specific condition [hyper-
tension (n = 4,481), diabetes (n = 5,663), and/or hyper-
cholesterolemia (n = 4,346)], as these participants would 
represent the target population for selected screening. 
Among the participants unaware of being affected, the 
associations between family history and the correspond-
ing trait were in the same direction as those observed in 
the entire sample but were weaker. Subjects with a posi- _ 
tive family history had higher levels of the corresponding 
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trait than those with a negative history (systolic blood 
pressure with and without paternal history of hyperten-
sion was 124.8 ± 0.4 mm Hg vs. 123.1 ± 0.3 mm Hg, 
p < 0.05, whereas with or without maternal history of hy-
pertension it was 125.3 ± 0.5mmHgvs.122.9 ± 0.3mm 
Hg, p < 0.05). The associations were statistically signifi-
cant (p < 0.05), except for those with a positive paternal 
history of hypercholesterolemia. Participants who were 
unaware of their family history of hypertension had high-
er systolic blood pressure levels than those who reported 
a negative family history, but this was only statistically 
significant for paternal (124.8 ± 0.4 mm Hg vs. 123.1 ± 
0.3 mm Hg, p < 0.05) and maternal (125.3 ± 0.5 mm Hg 
vs. 122.9 ± 0.3 mm Hg, p < 0.05) histories. Similar con-
clusions can be made for the associations between family 
history and the risk of disease (hypertension, diabetes, 
hypercholesterolemia) in participants who were unaware 
ofbeing affected (with or without excluding 'don't know' 
responses). In order to asses a recall bias concerning fam-
ily history of cardiovascular risk factors, we conducted 
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Table 5. Discrimination, calibration, and reclassification ability of family history to predict the risk of hypertension, diabetes, or 
hypercholesterolemia 
Including DK responses Coding DK responses as 'no' Comparison 
Hypertension 
Discrimination and calibration AUC HLpvalue AUC HLp value p va!ueh 
Age, sex 0.763 0.26 0.763 
+ father history 0.769a 0.21 0.768" 0.27 0.27 
+ mother history 0.772" 0.44 0.772a 0.50 0.50 
+ sibling hist01y 0.774" 0.05 0.773" 0.22 0.22 
+ parents and sibling hist01y 0.783" 0.13 0.781" 0.07 0.07 
Reclassification 
Full mode! NRI p value NRI p value NRI0 p value0 
+ father histo1y 0.016 0.03 0.013 0.03 0.002 0.65 
+ mother hist01y 0.029 0.0003 0.023 0.005 0.007 0.11 
+ sibling hist01y 0.024 0.006 0.018 0.03 0.006 0.16 
+ parents and sibling histo1y 0.047 <0.0001 0.040 <0.0001 0.005 0.39 
Diabetes 
Discrimination and calibration AUC HLpvalue AUC HL p value p vaiueh 
Age, sex 0.755 0.20 0.755 0.20 
+ father histo1y 0.766" 0.13 0.758 0.13 0.04 
+ mother history 0.774" 0.15 0.772" 0.03 0.32 
+ sibling histo1y 0.779" 0.04 0.776" 0.003 0.26 
+ parents and sibling history 0.798a 0.07 0.790" 0.04 0.02 
Reclassification 
Full mode! NRI pvalue NRI p value NRI0 p value0 
+ father history 0 0 
+ mother history 0 0 
+ sibling history 0.002 0.59 0.002 0.59 
+ parents and sibling history 0.009 0.12 0.008 0.15 
Hypercholesterolemia 
Discrimination and calibration AUC HL p value AUC HL pvalue p valueh 
Age, sex 0.687 <0.0001 0.687 <0.0001 
+ father histo1y 0.692" <0.0001 0.691 <0.0001 0.32 
+ mother history 0.689 <0.0001 0.688 <0.0001 0.34 
+ sibling history 0.695" <0.0001 0.694" <0.0001 0.49 
+parents and sibling history 0.698" 0.0001 0.698" 0.0005 0.37 
Reclassification 
Full mode! NRI p value NRI p value NRIC p value" 
+ father history 0.005 0.34 0.007 0.16 -0.001 0.78 
+ mother history 0.010 0.06 0.004 0.44 0.006 0.09 
+ sibling history 0.018 0.02 0.015 0.05 0.004 0.44 
+parents and sibling history 0.029 0.001 0.021 0.01 0.008 0.11 
DK = 'Don't know' response; AUC = area under the curve (test of discrimination); HL p value= p value from a Hosmer-Lemeshow 
goodness of fit test of calibration; NRI =net reclassification index. 
For reclassification a full mode! including fa1r;ily history was compared to a reduced mode! including only age and sex. 
a p < 0.05 for the comparison of the AUC including family history and the AUC including only age and sex as covariates. 
b p value for the comparison of AUC including 'don't know' responses as a separate category versus considered them as negative 
responses. 
c NRI and p value for the comparison of including 'don't know' responses as a separate category versus considering them as nega-
tive responses. 
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sensitivity analyses in which an interaction term between 
family history and a reported cardiovascular event (ei-
ther stroke or acute myocardial infarction) in the father 
or in the mother was added. None of the interaction terms 
was significant, which suggests that the risk of dichoto-
mized phenotype (i.e., hypertension, diabetes, hypercho-
lesterolemia) associated with corresponding parental his-
tory did not significantly differ according to the presence 
or absence of reported cardiovascular events in the par-
ents. 
Discussion 
We found that a positive family history of hyperten-
sion, diabetes, and hypercholesterolemia was strongly 
associated with higher levels of blood pressure, fasting 
glucose, and cholesterol, respectively. These associations 
were 'dose-dependent' in that the larger the number of 
affected first-degree relatives, the higher the correspond-
ing trait. Most studies on the family history of these phe-
notypes have reported the associated risk of hyperten -
sion, diabetes, or hypercholesterolemia, but few have an-
alyzed the independent effect size of a positive family 
history on the continuous underlying phenotype. From a 
standpoint of preventive medicine, our results suggest 
that family histories of hypertension, diabetes, and hy-
percholesterolemia should be used as a tool to detect sub-
jects at high cardiovascular risk in the general adult pop-
ulation, increasing the effectiveness of screening in the 
general population [21]. 
Tozawa et al. [22] also found a significant linear rela-
tionship between the number of first-degree relatives 
with a positive family history of hypertension and the 
participant's blood pressure level. Wada et al. [3] reported 
a similar relationship for diabetes and hyperglycemia but 
not for high blood pressure and dyslipidemia. This dis-
crepancy with our results and those of Tozawa et al. [22] 
may corne from the facts that (1) Wada et al. [3] did not 
consider separately 'don't know' and negative answers for 
the family histories and (2) the sample population size 
was smaller, with lower BMI and younger' age. Our re-
sults confirm those obtained by Lauer et al. [10] who 
found significantly higher total cholesterol levels in young 
adults with a positive family history of high cholesterol as 
compared to those with a negative history. Our results are 
also consistent with results of prospective studies show-
ing that parental blood pressure levels predict th ose in the 
offspring [4, 23], that parental hypercholesterolemia pre-
dicts elevated total cholesterol levels in the offspring [24], 
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or that a positive family history of diabetes predicts the 
incidence of impaired glucose tolerance and diabetes 
during follow-up [25-27]. 
Few population-based studies have analyzed the sib-
ling history of hypertension [3, 22], diabetes [3], and/or 
hypercholesterolemia [3]. In the present study, sibling 
history was as strongly associated with the risk of the cor-
responding dichotomized phenotype and with the un-
derlying continuous phenotype as were the parental his-
tories. Furthermore, the contribution of sibling history 
was independent of that of parental histories. In the 
Framingham Offspring study, sibling history of cardio-
vascular disease was more strongly associated with in-
creased risk of incident cardiovascular disease during 
follow-up than parental history of cardiovascular disease 
[28]. We found sibling histories to have higher positive 
predictive values than either paternal or maternal histo-
ries in predicting the risk of the underlying dichotomized 
phenotype. We found large differences in risk observed 
between the unadjusted and fully adjusted models for sib-
ling history for each trait, which underlines the key role 
of confounding factors (e.g., age and educational level) 
when analyzing the risk associated with a positive sibling 
history. Our data suggest that screening programs fo-
cused only on sibling family history niay be more effi-
cient than those taking paternal and maternal histories 
into account, and such programs should therefore be fur-
ther evaluated. 
Participants were unable to report on their family his-
tory of hypertension (41.8%) or hypercholesterolemia 
(50.2%) much more frequently than on their family his-
tory of diabetes (14.4%). Thorand et al. [15] found a high-
er prevalence of 'don't know' responses for maternal 
(8.8%) and paternal history (17.3%) of diabetes than we 
did (4.5% and 8.7%, respectively). In our study, 'don't 
know' responses were strongly associated with parent's 
gender, older age, and lower education level of the par-
ticipants. The increase in the prevalence of' don't know' 
responses with age [15, 16], the role of the education level 
[16], and the higher prevalence of 'don't know' responses 
for paternal as compared to maternal histories [15, 16, 29] 
have been previously reported. 
In the present study, unreported family history of 
hypertension was associated with higher systolic blood 
pressure levels, even after adjustment for age, education-
al level, and other potential confounders. This was not 
true for the family history of diabetes and hypercholes-
terolemia. To our knowledge, this finding bas never been 
_ described before. Also, we found that including 'don't 
know' responses in the models usually led to better dis-
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crimination, but without significantly improving the 
ability to reclassify participants as having the dichoto-
mized phenotype. Our results show that 'don't know' re-
sponses and negative family history of hypertension 
should be analyzed separately. Subjects who are unable to 
report on their family history of hypertension have a car-
diovascular risk profile that matches more closely those 
with a positive family history than those with a negative 
family history. A potential explanation is that 'hyperten-
sion' is less clearly perceived as a disease than diabetes. 
Given the high prevalence of hypertension (36%), the 
'don't know' responses will inevitably encompass many 
positive histories. Family history of hypercholesterol-
emia shares many common features with high blood 
pressure (high prevalence and high proportion of' don't 
know' responses) and lies somewhere between hyperten-
sion and diabetes. 
Another reason to separately consider 'don't know' re-
sponses is illustrated by the family history of diabetes. 
Whenever 'don't know' responses are ignored (i.e., clas-
sified as negative responses), the maternal history of dia-
betes is about twice as common as the paternal history 
[30-33]; by contrast, studies that took 'don't know' re-
sponses into account, such as this study, found a much 
lower difference between maternal and paternal history 
of diabetes [15, 16]. Failure to account for 'don't know' 
responses creates a reporting bias that leads to an over-
estimation of excess maternal transmission of diabetes 
[15, 16]. 
This study suffers from some limitations. First, it is 
cross-sectional, and we cannot show to what extent fam -
ily history predicts longitudinal changes in cardiovascu-
lar risk factors and future cardiovascular risk. Second, we 
rely on self-reported family history, which is subject to 
misclassification. The estimate of the prevalence of hy-
pertension among fathers was very low, which suggests 
that hypertension in fathers was underestimated. This 
further underlines the usefulness of sibling history. Also, 
we did not provide a definition for family history. How-
ever, family history of hypertension, diabetes, and hyper-
cholesterolemia was found to be very accurate when val-
idated against confirmed medical evidence [14]. Third, 
the less striking association between family history of hy-
percholesterolemia and elevated cholesterol levels can, at 
least partly, be explained by an overdiagnosis in this study 
because of the inclusion of treated patients in the group 
with elevated cholesterol levels. Many participants re-
ceiving lipid lowering drugs had lipid levels which would 
not qualify for our definition of dyslipidemia. Given the _ 
low prevalence of cardiovascular disease in the sample, 
Cardiovascular Family History 
our study was underpowered to analyze the associations 
of family history of cardiovascular risk factor with a per-
sonal history of cardiovascular events in the participants. 
Finally, our findings may not apply to non-Caucasians. 
In the present study, a positive family history of hyper-
tension, diabetes, and hypercholesterolemia was associ-
ated with clinically relevant effect sizes on the corre-
sponding cardiovascular risk factor. These results con-
firm that family history, whenever known, is a simple, 
specific, inexpensive, and powerful tool to assess cardio-
vascular risk in the general population. The importance 
to consider what subjects know about the health of their 
first-degree relatives may rapidly increase with the grow-
ing availability of detailed genotypic information, such as 
to guide selective genetic testing in order to target preven-
tive measures to high-risk individuals. Our results fur-
ther suggest that 'don't know' responses do in fact con-
tain information on the level of risk factor. This aspect 
should be carefully considered in future research focus-
ing on the family history of cardiovascular risk factors. 
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